After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

A search of the English-language medical literature was performed ... Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment ...

Medical treatments include bronchodilators ... prolonged or severe exacerbations of COPD. Hence, in some European and extra-European countries, mucolytics are prescribed widely since they appear ...

COPD exacerbations can be life threatening ... These can include recommendations for medical treatments, lifestyle changes, and rehabilitation programs. Spirometry assists in staging and treatment ...

The researchers found that the incidence of a first moderate or severe COPD exacerbation was higher in patients who received budesonide-glycopyrrolate-formoterol (hazard ratio, 1.09; 95 percent ...

“Emphysema is part of a group of lung conditions which comes under the umbrella term chronic obstructive pulmonary disease ...